Fate Therapeutics
FATE
FATE
265 hedge funds and large institutions have $5.67B invested in Fate Therapeutics in 2021 Q3 according to their latest regulatory filings, with 37 funds opening new positions, 104 increasing their positions, 83 reducing their positions, and 42 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
15% less funds holding in top 10
Funds holding in top 10: 13 → 11 (-2)
31% less capital invested
Capital invested by funds: $8.19B → $5.67B (-$2.52B)
65% less call options, than puts
Call options by funds: $8.95M | Put options by funds: $25.5M
Holders
265
Holding in Top 10
11
Calls
$8.95M
Puts
$25.5M
Top Buyers
| 1 | +$203M | |
| 2 | +$50.2M | |
| 3 | +$37M | |
| 4 |
LPC
Lone Pine Capital
Greenwich,
Connecticut
|
+$26.7M |
| 5 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$24.1M |
Top Sellers
| 1 | -$249M | |
| 2 | -$49.5M | |
| 3 | -$45.3M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$30.1M |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
-$23.9M |